Skip to main content
. Author manuscript; available in PMC: 2015 Nov 13.
Published in final edited form as: Endocr Relat Cancer. 2014 Nov 6;22(1):1–9. doi: 10.1530/ERC-14-0360

Table 3.

Pathological characteristics of the patient population
Characteristic No. of patients (= 23) %
Primary tumor size (cm)
    Median 2
    Range 0.4–3.5
Tumor necrosis
    Present 1 4
    Absent 12 52
    Unknown 10 44
Angioinvasion
    Present 7 30
    Absent 16 70
Ki-67 (%)
    Median 5
    Range 1–20
SSTR expression
    SSTR1
        Low (negative/weak) 2/5 8/22
        High (moderate/strong) 9/6 39/26
        Unknown 1 4
    SSTR2
        Low (negative/weak) 1/8 4/35
        High (moderate/strong) 12/1 52/4
        Unknown 1 4
    SSTR3
        Low (negative/weak) 0/7 0/30
        High (moderate/strong) 13/2 57/8
        Unknown 1 4
    SSTR4
        Low (negative/weak) 0/16 0/69
        High (moderate/strong) 5/1 22/4
        Unknown 1 4.5
    SSTR5
        Low (negative/weak) 0/5 0/22
        High (moderate/strong) 14/3 61/13
        Unknown 1 4